Cresco Labs Inc.
CRLBF
$0.63
-$0.0379-5.68%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.33% | -5.28% | -6.55% | -7.28% | -8.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.33% | -5.28% | -6.55% | -7.28% | -8.35% |
| Cost of Revenue | -11.90% | -15.92% | -16.28% | -10.20% | -6.20% |
| Gross Profit | 2.40% | 8.18% | 5.98% | -3.83% | -10.75% |
| SG&A Expenses | -13.75% | -22.50% | -24.05% | -22.52% | -17.11% |
| Depreciation & Amortization | -11.28% | 27.78% | 39.28% | 26.19% | 18.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.57% | -17.24% | -17.91% | -14.17% | -9.93% |
| Operating Income | 69.60% | 244.78% | 282.03% | 115.82% | 12.07% |
| Income Before Tax | 92.77% | 99.73% | 27.78% | 12.47% | -15.76% |
| Income Tax Expenses | 51.36% | 13.22% | -58.43% | -58.83% | -62.95% |
| Earnings from Continuing Operations | 66.37% | 84.66% | 36.58% | 29.95% | 16.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -422.15% | -143.99% | -149.69% | -106.14% | 14.07% |
| Net Income | 57.59% | 80.14% | 26.21% | 26.60% | 17.22% |
| EBIT | 69.60% | 244.78% | 282.03% | 115.82% | 12.07% |
| EBITDA | 33.26% | 102.91% | 112.25% | 62.52% | 15.94% |
| EPS Basic | 59.83% | 81.89% | 33.93% | 33.10% | 23.89% |
| Normalized Basic EPS | -506.57% | -206.06% | -3,554.55% | 616.67% | -15.43% |
| EPS Diluted | 59.83% | 81.89% | 33.93% | 33.10% | 23.89% |
| Normalized Diluted EPS | -506.57% | -206.06% | -3,554.55% | 616.67% | -15.43% |
| Average Basic Shares Outstanding | 6.71% | 9.13% | 11.57% | 10.57% | 8.58% |
| Average Diluted Shares Outstanding | 6.71% | 9.13% | 11.57% | 10.57% | 8.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |